DRW Securities’s Jaguar Health JAGX Stock Holding History

DRW Securities’s Portfolio JAGX Stock Details JAGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-560	Closed	-$16.6K	–	1525
2025 Q4	$16.6K	Sell	560 -2,299	-80%	-$118K	﹤0.01%	1172
2025 Q3	$212K	Buy	+2,859	New	+$194K	﹤0.01%	1047

Other funds holding JAGX

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LSA

Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DRW Securities's JAGX Position: Q1 2026 in Review

DRW Securities sold out of Jaguar Health (JAGX) in Q1 2026, closing a stake of 560 shares — an estimated $16.6K sold.

DRW Securities first reported a position in JAGX in Q3 2025 and held it in 2 quarters. The position peaked at $212K in Q3 2025. 10 funds tracked by Wall St. Rank hold JAGX as of Q1 2026.

DRW Securities reported no remaining Jaguar Health position as of Q1 2026 after selling out during the quarter.
DRW Securities sold 560 Jaguar Health shares in Q1 2026, an estimated $16.6K.
DRW Securities first reported a position in Jaguar Health in Q3 2025 and held it in 2 quarters.
DRW Securities's Jaguar Health position peaked at $212K in Q3 2025.
10 funds tracked by Wall St. Rank held Jaguar Health as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.